Bosutinib vs imatinib for newly diagnosed chronic myeloid leukemia (BFORE trial) : 24-month efficacy update and results by 3-month BCR-ABL1 transcript levels
2018
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI